期刊文献+

比较奥氮平与阿立哌唑治疗精神分裂症的临床疗效 被引量:3

To Compare the Clinical Efficacy of Olanzapine and Aripiprazole for Treating Schizophrenia
下载PDF
导出
摘要 目的对比奥氮平与阿立哌唑治疗精神分裂症的临床疗效。方法选取2014年8月至2016年8月我院收治的100例精神分裂症患者为研究对象,分为两组,对照组患者采用奥氮平治疗,观察组患者采用阿立哌唑治疗,对比两组临床疗效。结果经过8周治疗后,两组患者的PANSS总分和各个因子评分均显著降低(P<0.05),但是两组之间的差异不存在统计学意义(P>0.05);对照组患者的临床治疗总有效率为88%,观察组为90%,两组对比差异不存在统计学意义(P>0.05)。结论奥氮平与阿立哌唑均能够有效治疗精神分裂症,疗效相当。 Objective To compare the clinical efficacy of olanzapine and aripiprazole in the treatment of schizophrenia. Methods From August 2014 to August 2016 in our hospital 100 cases of mental patients with schizophrenia as the research object, divided into two groups, the control group was treated with olanzapine treatment, observation group of patients with aripiprazole treatment, compared two groups of clinical curative effect. Results After 8 weeks of treatment, PANSS total score and each factor score of the two groups were significantly decreased(P〈0.05), but the difference between the two groups was not statistically significant(P〈0.05); the control of clinical patients in the treatment group the total effective rate was 88%, the observation group was 90%, the difference between the two groups was not statistically significant(P〈0.05). Conclusion Olanzapine and aripiprazole can effectively treat schizophrenia, the curative effect is equivalent.
作者 朱银波 ZHU Yin-bo(Jingjiang Second People's Hospital, Jingjiang 214500, Chin)
出处 《中国医药指南》 2018年第18期11-12,共2页 Guide of China Medicine
关键词 奥氮平 阿立哌唑 精神分裂症 临床疗效 Olanzapine Aripiprazole Schizophrenia Clinical efficacy
  • 相关文献

参考文献5

二级参考文献35

  • 1杜波,赵淑敏,田国庆,刘杰,张香云,张艳敏,张旭静,苏丽惠,韩彦超.阿立哌唑对精神分裂症患者血清催乳素及体重的影响[J].中国全科医学,2006,9(13):1065-1066. 被引量:15
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准(CCMD-3)[M].第3版.济南:山东科学技术出版社,2001.
  • 3金卫东,马永春.循证精神病学[M].北京:人民军医出版社,2010:85-98.
  • 4Henderson DC, Fan X, Copland PM, et al. Afiprazole added to o- verweight and obese olanzapine-treatde schizophrenia patients~J]. J Clin Psyehopharmaeo1,2009,29 ( 2 ) : 165-169.
  • 5Fagiolini A, Canas F, Gallhofer F, et al. Strategies for sueeesdul clinical management of schizophrenia with ziprasidone [ J ]. Expert Opin Pharmaeother,2010,11 ( 13 ) :2199-2220.
  • 6Kroeze WK, Hufeisen S J, Popadak BA, et al. HI-histamine receptor affinity predicts short-term weight gain for typical and atypical anti- psychotic drugs[ J]. Neuropsyehopharmaeology ,2003,28 ( 3 ) :519- 526.
  • 7Henderson DC, Kunkel L, Nguyen DD, et al. An exploratory open- label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia[J].Aeta Psyehiatr Seand, 2006,113 ( 2 ) : 142-147.
  • 8Roth TL, Lubin FD, Sodhi M, et al. Epigenetic mechanisms in schizophrenia[J]. Biochimica Biophysica Acta (BBA)-General Subjects, 2009, 1790(9): 869-877.
  • 9World Health Organization. ICD-10: international statistical classification of diseases and related health problems[M]. 10th. Geneva: World Health Organization, 1992.
  • 10American Psychiatric Association. Diagnosis and statistical manual of mental disorders[M]. 5th. Arlington: American Psychiatric Publishing, 1994.

共引文献85

同被引文献19

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部